Table 1. Recent studies reporting transplantation for PBC.
| Author | Year | Country | PBC cases (n) | Protocol biopsy | Follow-up period (yr) mean (range) | Patient survival (5-/10-year) (%) | Reccurrence rate n (%) | Time to recurrence (yr) | Graft loss due to recurrence (n) |
| Sebagh et al. (167) | 1998 | France | 69 | Yes | 1–10 | NA | 6 (9) | 6.3 | 0 |
| Renz et al. (168) | 2002 | US | 58 | Yes | 5.3 ± 2.4 | NA | 8 (14) | NA | 2 |
| Sanchez et al. (169) | 2003 | US | 156 | Tes | 6 (1–15) | NA | 17 (13) | 4.1 (1.1–7.1) | 1 |
| Levitsky et al. (170) | 2003 | US | 46 | No | NA | NA | 7 (15) | 6.5 (2.3–10) | 0 |
| Khettry et al. (171) | 2003 | US | 43 | No | 7 (1–17) | NA | 8 (19) | 3.5 (0.1–14) | 0 |
| Neuberger et al. (14, 172) | 2004 | UK | 485 | Yes | 6.6 | 78/67 | 114 (23) | 10 (cyclosporine)/5.2 (tacrolimus) | 3 |
| Guy et al. (173) | 2005 | US | 48 | No | 4.2 (1–12) | NA | 17 (35) | 3.3 ± 2.8 | 1 |
| Charatcharoenwitthaya et al. (174) | 2007 | US | 154 | Yes | 11 (1–21) | 90/66 | 52 (34) | 3.5 (0.3–18) | 2 |
| Morioka et al. (175) | 2007 | Japan | 50 | No | 2.4 (0–10) | NA | 9 (18) | 1.6 (0.2–5.7) | 0 |
| Campse et al. (176) | 2009 | US | 70 | No | 7.8 (0.3–17) | 72/54 | 18 (26) | 4.8 (0.4–13) | 0 |
| Jacob et al. (177, 178) | 2010 | Germany | 121 | Yes | 10 (0.4–19) | 87/84 | 18 (15) | 5 (3–10) | 2 |
| Montano-Loza et al. (179) | 2010 | Canada | 108 | No | 7.3 (0.2–19) | 86/76 | 28 (26) | 5.8 (0.5–16) 10.8 (cyclosporine)/6 (tacrolimus) | NA |
| Manousou et al. (180) | 2010 | UK | 103 | Yes | 9 (1–20) | NA | 36 (35) | 3.7 (1–17) | 6 |
| Kaneko et al. (181) | 2011 | Japan | 81 | No | 6.2 (0.1–13) | NA | 1 (1) | 5.1 | 0 |
Abbreviations: NA, not available; PBC, primary biliary cirrhosis